Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Free Cash Flow: 2024-2025

Historic Free Cash Flow for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to -$13.3 million.

  • Pyxis Oncology's Free Cash Flow rose 9.46% to -$13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72.4 million, marking a year-over-year change of. This contributed to the annual value of -$57.9 million for FY2024, which is 25.22% up from last year.
  • Per Pyxis Oncology's latest filing, its Free Cash Flow stood at -$13.3 million for Q3 2025, which was up 23.09% from -$17.3 million recorded in Q2 2025.
  • Pyxis Oncology's Free Cash Flow's 5-year high stood at -$3.0 million during Q2 2024, with a 5-year trough of -$22.5 million in Q1 2025.
  • Moreover, its 2-year median value for Free Cash Flow was -$17.3 million (2025), whereas its average is -$15.9 million.
  • The largest annual percentage gain for Pyxis Oncology's Free Cash Flow in the last 5 years was 9.46% (2025), contrasted with its biggest fall of 474.09% (2025).
  • Pyxis Oncology's Free Cash Flow (Quarterly) stood at -$19.3 million in 2024, then increased by 9.46% to -$13.3 million in 2025.
  • Its Free Cash Flow stands at -$13.3 million for Q3 2025, versus -$17.3 million for Q2 2025 and -$22.5 million for Q1 2025.